Collaborators
Dr Bjorn CochloviusDr Jutta Amersdorffer, Otsuka Pharma, Prostate cancer, 2012
Guest Lectures
Prostate Cancer in Europe: Future Advancements in Screening and Control, Centre for Parliamentary Studies, Silken Berlaymont Hotel, Brussels., 2011
Is the UK system for rationing access to the new cancer drugs the most rational in the world?, ACP New Consultants Group Meeting - Lilly Debate, Hyatt Regency Hotel, Birmingham, 2011
Current treatment of prostate cancer, dilemmas and trials, British Institution of Radiology Meeting on Male Imaging., 36 Portland Place, London, W1B 1AT, 2010
Invitation to debate on life-saving drugs, Hull York Medical School, York University, York Medical Society Rooms, 23 Stonegate, York., 2010
'Local autonomy and the National Health Service, Westminster Health Forum Keynote Seminar: The Cancer Reform Strategy - assessing the impact so far and next steps., Great Hall BMA House, Tavistock Square, London WC1H 9JP, 2010
Local Autonomy, Oncology Futures symposium., Chandos House (Royal Society of Medicine) 2 Queen Anne Street, W1G 9LQ, 2009
Advanced metastatic disease: challenges in the patients management, Top Seminar II edition, Scientific Organizing Secretariat, Prex S.p.A. , Via A.Fava, 25, 20125 Milano (MI) Italy, 2009
REACTION TO NICE GUIDELINES: CLINICAL VS COST EFFECTIVENESS, ALL DAY MEETING ON RENAL CANCER organised by MA Healthcare Ltd (c, Regents College, London NW1 4NS, 2009
THE CHALLENGE OF PROSTATE CANCER, 30th Institute of Clinical Cancer Research Conference, Birmingham. Oncology Session., Birmingham, 2009
"Can the doctor share decision-making with patients" + "Physicians or Prayers: who should have the say on treatment strategies", Pfizer Oncology Europe Workshop, ASCO, Chicago, ASCO, Chicago, 2008
Research Staff
Research Student Supervision
Alshaker,H, Leptin and SK-1 in prostate cancer
Gillmore,R, Targeting the Willms' tumour antigen in the immunotherapy of prostate cancer
Gronau,J, SK-1 in prostate cancer
Kalofonou,F, Characterisation of AR-modulatory microRNAs in Prostate Cancer
King,J, Wilms' tumour antigen (WT1) a a target for tumour immunotherapy of prostate cancer
Mazhar,D, Gene ICE as applied to prostate cancer
Ngan,S, Identifying targets for prostate cancer treatment